Observational study of lipid profile and LDL particle size in patients with metabolic syndrome

• Published in: Lipids in health and disease 2011-09, Vol.10 (1), p.162-162
• Main Authors: Sancho-Rodríguez, Natalia, Avilés-Plaza, Francisco V, Granero-Fernández, Esteban, Hernández-Martínez, Antonio M, Albaladejo-Otón, María Dolores, Martínez-Mernández, Pedro, Parra-Pallarés, Soledad
• Format: Article
• Language: English
• Subjects: Adult; Aged; Analysis and chemistry; Apolipoproteins; Atherosclerosis; Biomarkers - blood; Blood; Body Weights and Measures; Cardiovascular disease; Cardiovascular Diseases - epidemiology; Cardiovascular Diseases - etiology; Care and treatment; Cholesterol; Diagnosis; Diet; Female; Humans; Hyperglycemia - epidemiology; Hyperglycemia - etiology; Hyperlipidemias - epidemiology; Hyperlipidemias - etiology; Hypertension - epidemiology; Hypertension - etiology; LDLC particle size; Lipids; Lipids - blood; Lipoproteins, LDL - blood; Lipoproteins, LDL - chemistry; Low density lipoprotein; Low density lipoproteins; Male; Metabolic diseases; Metabolic Syndrome; Metabolic Syndrome - blood; Metabolic Syndrome - physiopathology; Middle Aged; Nutrition; Particle Size; Physiological aspects; Risk Factors; Sex Characteristics; Spain - epidemiology; Triglycerides - blood
• ISSN: 1476-511X; 1476-511X
• DOI: 10.1186/1476-511X-10-162

The atherogenic lipoprotein phenotype is characterized by an increase in plasma triglycerides, a decrease in high-density lipoprotein cholesterol (HDLc), and the prevalence of small, dense-low density lipoprotein cholesterol (LDLc) particles. The aim of this study was to establish the importance of LDL particle size measurement by gender in a group of patients with Metabolic Syndrome (MS) attending at a Cardiovascular Risk Unit in Primary Care and their classification into phenotypes. One hundred eighty-five patients (93 men and 92 women) from several areas in the South of Spain, for a period of one year in a health centre were studied. Laboratory parameters included plasma lipids, lipoproteins, low-density lipoprotein size and several atherogenic rates were determinated. We found differences by gender between anthropometric parameters, blood pressure and glucose measures by MS status. Lipid profile was different in our two study groups, and gender differences in these parameters within each group were also remarkable, in HDLc and Apo A-I values. According to LDL particle size, we found males had smaller size than females, and patients with MS had also smaller than those without MS. We observed inverse relationship between LDL particle size and triglycerides in patients with and without MS, and the same relationship between all atherogenic rates in non-MS patients. When we considered our population in two classes of phenotypes, lipid profile was worse in phenotype B. In conclusion, we consider worthy the measurement of LDL particle size due to its relationship with lipid profile and cardiovascular risk.